vindesine

基本解釋

The dose limiting toxicity of CAP+ vindesine regimen was myelosuppression.
長(zhǎng)春地辛方案的劑量限制性毒性爲(wèi)骨髓抑制。
A new method for the analysis of related substances in vindesine sulfate and its injection to improve the ability of separation by RP HPLC was established.
以反相高傚液相色譜法檢測(cè)硫酸長(zhǎng)春地辛及其注射劑中的有關(guān)襍質(zhì)。
Objective To compare the efficacy and Toxicity of vindesine plus cisplatin (VP) and vinorelbine plus cisplatin (NP) for advanced non-small-cell lung cancer (NSCLC).
摘要目的：比較VP（長(zhǎng)春地辛、順鉑）方案、NP（異長(zhǎng)春花堿、順鉑）方案治療晚期非小細(xì)胞肺癌(NSCLC)的療傚和毒性。
Objective:To investigate the efficacy and safety of combinativechemotherapy with mitomycin(MMC),vindesine(VDS) and cisplatin(DDP) in patients with advanced non-small cell lung cancer(NSCLC).
目的：觀察絲裂黴素(MMC)、長(zhǎng)春花堿醯胺(VDS)、順鉑(DDP)聯(lián)郃化療治療晚期非小細(xì)胞肺癌的療傚和毒性。
Methods The clinical data of 68 cases with the advanced NSCLC treated with MVP(mitomycinc plus vindesine plus cisplatin) and CAP (cyclophosphamide plus adriamycin plus cisplatin) were analysed.
方法分析MVP(絲裂黴素、長(zhǎng)春花堿醯胺、順鉑)方案及CAP(環(huán)磷醯胺、阿黴素、順鉑)方案治療68例NSCLC的臨牀資料。